Cargando…
A Novel Puncturable Atrial Septal Defect Occluder: The Results of Preclinical Experiment and First-in-Human Study
ReAces is a novel puncturable transcatheter atrial septal defect occluder. The device success rate was 100% (n = 14 of 14) in the animal experiment. Four swine successfully received puncture of the device 60 days after implantation of the device. The acute procedure success rate in the 10 patients w...
Autores principales: | Zhang, Xiaochun, Chen, Shasha, Li, Wei, Jilaihawi, Hasan, Piayda, Kerstin, Sievert, Horst, Zhou, Daxin, Pan, Wenzhi, Ge, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831856/ https://www.ncbi.nlm.nih.gov/pubmed/36644281 http://dx.doi.org/10.1016/j.jacbts.2022.06.010 |
Ejemplares similares
-
Rescue atrial septal defect closure with the new GORE(®) cardioform atrial septal defect occluder
por: Pizzuto, Alessandra, et al.
Publicado: (2022) -
Prevention of Migrating Atrial Septal Occluder in Large Hole Atrial Septal Defect Intervention by Snare
por: Truong Hoai, Lam, et al.
Publicado: (2023) -
Embolization of an Atrial Septal Defect Occluder Device Into the Left Ventricle
por: Hierlmeier, Bryan J, et al.
Publicado: (2020) -
Migration of an Atrial Septal Defect Occluder in a Pregnant Patient
por: Mendez-Ruiz, Alan, et al.
Publicado: (2023) -
Device-related thrombosis on atrial septal defect occluder after simultaneous closure of left atrial appendage and atrial septal defect: a case report
por: He, Lu, et al.
Publicado: (2019)